Jeffrey Calabrese SEC EDGAR Filings (CIK 0001892279)

SEC EDGAR filings, ownership reports, and insider transactions for Jeffrey Calabrese.

Business address
Aerie Pharmaceuticals, Inc., 4301 Emperor Blvd., Suite 400, Durham, NC, 27703
Get insider transactions for this reporting owner
Jeffrey Calabrese has filed 6 SEC EDGAR filings since 08 Nov 2021

Latest Filings

Recent SEC filings for Jeffrey Calabrese including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 21 Nov 2022 21 Nov 2022 001-36152
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Nov 2022 01 Nov 2022 001-36152
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 16 Aug 2022 14 Aug 2022 001-36152
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 13 Jul 2022 01 Jul 2022 001-36152
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Jul 2022 01 Jul 2022 001-36152
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 08 Nov 2021 29 Oct 2021 001-36152

About this filer

Jeffrey Calabrese files with the SEC under CIK 0001892279. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages